Indeed, Umesalma et al. showed that reactivation of endogenous PP2A with a small‐molecule activator of PP2A (SMAP) reduced p‐AKTSer473 in a novel RAB‐like GTPase RABL6A‐dependent manner and blocked the growth of neuroendocrine tumour cells.16 Here, PTPA is linked to neuroendocrine neoplasm.